Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized intranasal dexmedetomidine dosing in children based on pharmacokinetics and pharmacogenomics
ChiCTR1800015340Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children's Medical Centre
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in hemangioma, sponsored by Guangzhou Women and Children's Medical Centre. Primary endpoints: Success rate of sedation, Blood concentration and 1 more. Started Mar 2018; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hemangioma
Beyond the preview
Go deeper on ChiCTR1800015340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015340.